ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 33 filers reported holding ATYR PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $69,000 | +9.5% | 126,196 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $63,000 | -38.8% | 126,196 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $103,000 | -10.4% | 126,196 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $115,000 | -85.2% | 126,196 | -50.0% | 0.00% | -75.0% |
| Q1 2018 | $776,000 | +75.6% | 252,392 | +100.0% | 0.01% | -20.0% |
| Q4 2017 | $442,000 | -30.6% | 126,196 | 0.0% | 0.01% | -33.3% |
| Q3 2017 | $637,000 | +46.4% | 126,196 | 0.0% | 0.02% | +50.0% |
| Q2 2017 | $435,000 | -1.6% | 126,196 | 0.0% | 0.01% | -9.1% |
| Q1 2017 | $442,000 | +39.0% | 126,196 | -14.7% | 0.01% | +37.5% |
| Q4 2016 | $318,000 | – | 148,008 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $1,485,000 | 0.74% |
| Artal Group S.A. | 500,000 | $406,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 94,466 | $77,000 | 0.01% |
| VIKING GLOBAL INVESTORS LP | 1,384,300 | $1,125,000 | 0.01% |
| Glen Harbor Capital Management LLC | 153,238 | $125,000 | 0.00% |
| Tyers Asset Management LLC | 72,112 | $59,000 | 0.00% |
| Elkfork Partners LLC | 99,154 | $81,000 | 0.00% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $65,000 | 0.00% |
| A.R.T. Advisors, LLC | 43,316 | $35,000 | 0.00% |
| Meadow Creek Investment Management LLC | 126,196 | $103,000 | 0.00% |